[This Week's IPO] August Third Week Demand Forecast and Subscription Schedule

This month (August) in the third week, M83 and ENCell will conduct their general public offerings.

◆M83= The public offering price was set at 16,000 KRW, exceeding the upper limit of the desired price band (11,000~13,000 KRW). The demand forecast competition rate recorded 1,024.72 to 1. The general subscription will take place on the 12th and 13th, and the company is scheduled to be listed on KOSDAQ on the 22nd. ShinYoung Securities is the lead underwriter.

M83, established in February 2020, is a VFX (Visual Effects) specialized company. It has served as the main studio for large-scale VFX in films such as "Noryang: Sea of Death," "Hansan: Rising Dragon," "Space Sweepers," and dramas like "Vincenzo" and "Sweet Home 2."

◆ENCell= The public offering price was set at 15,300 KRW, the highest point of the desired price band. The institutional investor demand forecast competition rate recorded 949 to 1. After the general public subscription on the 12th and 13th, the company plans to enter the KOSDAQ market on the 23rd. NH Investment & Securities is the lead underwriter.

ENCell was founded in 2018 by Professor Jang Jong-wook of Samsung Seoul Hospital. The company is engaged in ▲ CDMO business for cell and gene therapies ▲ development of next-generation mesenchymal stem cell therapy (EN001) new drugs targeting rare and intractable muscle diseases such as Charcot-Marie-Tooth disease (CMT), Duchenne muscular dystrophy (DMD), and sarcopenia.